Bio-Thera Solutions clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 0 with minor changes only.

1. Notable

   BAT4406F Injection · Neuromyelitis Optica Spectrum Disorders

   Primary and study completion pushed from May 31, 2026 to Dec 31, 2027

   Bio-Thera Solutions·Phase 2· NCT06044350· Registry history of NCT06044350 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

2. Notable

   Of BAT6026

   Primary completion pushed from Jun 1, 2026 to Dec 31, 2026

   Also in this update: Study completion pushed from Jun 30, 2026 to Dec 31, 2026

   Bio-Thera Solutions·Phase 1/2· NCT06094179· Registry history of NCT06094179 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

3. Notable

   Characteristics, and Preliminary Efficacy of the Combination of…Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 · Advanced Solid Tumors

   Primary completion pushed from Apr 3, 2026 to Nov 30, 2026

   Also in this update: Study completion pushed from Jul 28, 2026 to Nov 30, 2026

   Bio-Thera Solutions·Phase 1/2· NCT06341114· Registry history of NCT06341114 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

4. Notable

   Profile, and Initial Clinical Efficacy of BAT 8010 for Injection…Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 · Locally Advanced or Metastatic Tumors

   Primary completion pushed from Nov 9, 2026 to Feb 29, 2028

   Also in this update: Enrollment closed, study ongoing; Study completion pushed from Dec 9, 2026 to May 30, 2028

   Bio-Thera Solutions·Phase 1/2· NCT06376136· Registry history of NCT06376136 on ClinicalTrials.gov (opens the registry)

   Sep 30, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.